SETEVRI Trademark

Trademark Overview

On Wednesday, December 12, 2007, a trademark application was filed for SETEVRI with the United States Patent and Trademark Office. The USPTO has given the SETEVRI trademark a serial number of 79048594. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, December 13, 2017. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The SETEVRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use
setevri

General Information

Serial Number79048594
Word MarkSETEVRI
Filing DateWednesday, December 12, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, December 13, 2017
Registration Number3564881
Registration DateTuesday, January 20, 2009
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 4, 2008

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 21, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressJP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressJP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressJP

Trademark Events

Event DateEvent Description
Friday, June 29, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, June 29, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, April 7, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Monday, May 16, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, May 16, 2016INVALIDATION PROCESSED
Thursday, April 21, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 25, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 10, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 7, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 21, 2015CANCELLED SECTION 71
Monday, January 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 7, 2009FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 7, 2009FINAL DISPOSITION PROCESSED
Monday, April 20, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 20, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, November 4, 2008PUBLISHED FOR OPPOSITION
Wednesday, October 15, 2008NOTICE OF PUBLICATION
Monday, September 29, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 29, 2008ASSIGNED TO LIE
Thursday, September 18, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 17, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, September 17, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 17, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, September 17, 2008EXAMINERS AMENDMENT -WRITTEN
Monday, September 15, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 15, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 15, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 15, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 12, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 12, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 11, 2008REFUSAL PROCESSED BY IB
Monday, March 24, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 24, 2008REFUSAL PROCESSED BY MPU
Saturday, March 22, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 21, 2008NON-FINAL ACTION WRITTEN
Thursday, March 20, 2008ASSIGNED TO EXAMINER
Friday, February 8, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, February 7, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

setevri disease disorders infection inflammatory pain musculoskeletal inflammation fungal bacterial viral